The "Clinical Snapshot" series provides a concise examination of a clinical presentation including history, treatment, patient education, and nursing measures. Using the format here, you are ...

Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

With this agreement, Johnson & Johnson adds Intra-Cellular Therapies’ CAPLYTA ® (lumateperone), a once-daily oral therapy approved to treat adults ... have included pruritus, rash (e.g ...

Patients usually present in the late spring or summer in temperate zones and may state that this is the rash they get every ... eruption consisting of chronic pruritic follicular papules and ...

Our skin is often seen as merely a protective barrier, shielding us from external elements. However, this complex organ is ...

Chronic itch, also known as pruritus, is a distressing condition that can significantly impact the quality of life for those affected. It can arise from various underlying causes, including skin ...

ATTO-1310 is being evaluated as a potential systemic treatment for people living with pruritic conditions such as chronic pruritus of unknown origin ... and pharmacokinetics of ATTO-1310 in healthy ...

Nemolizumab monotherapy may be an effective treatment for reducing pruritus and disease severity in adults with moderate to severe prurigo nodularis.

Unexpectedly, more than 40 adults have also contacted Dr. Weinberger to let him know that their chronic cough also resolved during or soon after viewing the video, even after some of them had ...

Rosacea, a chronic and often misunderstood skin condition, is marked by persistent facial redness, visible blood vessels, and, in some cases, inflammatory bumps. The causes of rosacea are not yet ...